Liposomal entrapment of cefoxitin to improve cellular viability and function in human saphenous veins

Artificial Organs

Volumn 27, Issue 7, 2003, Pages 623-630

  Park, Jong Chul ^a   Suh, Hwal ^a   Sung, Hak Joon ^a   Han, Dong Wook ^a   Lee, Dong Hee ^a   Park, Bong Joo ^a   Park, Young Hwan ^a   Cho, Bum Koo ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Cellular viability; Endothelial nitric oxide synthase; Human saphenous vein; Liposomal cefoxitin; Sterilization effect

Indexed keywords

ENDOTHELIAL CELLS; NITRIC OXIDE;

CEFOXITIN; CELLULAR FUNCTION; CELLULAR VIABILITY; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIAL-CELLS; ENTRAPMENT EFFICIENCY; HUMAN SAPHENOUS VEIN; LIPOSOMAL CEFOXITIN; PRE-TREATMENTS; STERILIZATION EFFECT;

STERILIZATION (CLEANING);

CEFOXITIN; LIPOSOME; NITRIC OXIDE SYNTHASE;

ALLOGRAFT; ARTERY GRAFT; ARTICLE; CELL FUNCTION; CELL VIABILITY; DRUG EFFECT; DRUG RELEASE; DRUG TISSUE LEVEL; ENZYME ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; INSTRUMENT STERILIZATION; PRIORITY JOURNAL; SAPHENOUS VEIN;

GRIFFONIA SIMPLICIFOLIA;

EID: 0038574530     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.2003.07164.x     Document Type: Article

References (32)

1. Pratesi C, Russo D, Dorigo W, Chiti E. Antibiotic prophylaxis in clean surgery: vascular surgery. J Chemother 2001;13:123-8.
2. Carbognani P, Spaggiari L, Solli P, Corradi A, Cantoni AM, Barocelli E. Experimental tracheal transplantation using a cryopreserved aortic allograft. Eur Surg Res 1999;31:210-5.
3. Ruddle AC, George S, Armitage WJ, MacGowan A, McCulloch S, Brookes ST, Mitchell DC. Venous allografts prepared from stripped long saphenous vein. Is there a need for antibiotic sterilisation? Eur J Vasc Endovasc Surg 1998;15:444-8.
4. Hu JF, Gilmer L, Hopkins R, Wolfinbarger L Jr. Effects of antibiotics on cellular viability in porcine heart valve tissue. Cardiovasc Res 1989;23:960-4.
5. Schmehl MK, Bank HL, Brockbank KG. Effects of antibiotics on the endothelium of fresh and cryopreserved canine saphenous veins. Cryobiology 1993;30:164-71.
6. Chandran S, Roy A, Mishra B. Recent trends in drug delivery systems: liposomal drug delivery system-preparation and characterization. Indian J Exp Biol 1997;35:801-9.
7. Yoshikawa Y, Miyazaki M, Houjou T, Komuta Y, Yoshikawa H, Takada K. Biodistribution of cyclosporin encapsulated in liposomes modified with bioadhesive polymer. J Pharm Pharmacol 1997;49:661-8.
8. Rosa P, Clementi F. Absorption and tissue distribution of doxorubicin entrapped in liposomes following intravenous or intraperitoneal admistration. Phamacology 1983;26:221-9.
9. Goren D, Gabizon A, Barenholz Y. The influence of physical characteristics of liposomes containing doxorubicin on their pharmacological behavior. Biochim Biophys Acta 1990;1029:285-94.
10. Kresta A, Shek PN, Odumeru J, Bohnen JM. Distribution of free and liposome-encapsulated cefoxitin in experimental intra-abdominal sepsis in rats. J Pharm Pharmacol 1993;45:779-83.
11. st Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C. 1991.
12. Ostro MJ. Liposomes. Sci Am 1987;256:102-11.
13. Hirano K, Hunt CA. Lymphatic transport of liposome-encapsulated agents: effects of liposome size following intraperitoneal administration. J Pharm Sci 1985;74:915-21.
14. Segal AW, Willis EJ, Richmond JE, Slavin G, Black CD, Gregoriadis G. Morphological observations on the cellular and subcellular destination of intravenously administered liposomes. Br J Exp Pathol 1974;55:320-7.
15. Nacucchio MC, Bellora MJ, Sordelli DO, D'Aquino M. Enhanced liposome-mediated activity of piperacillin against staphylococci. Antimicrob Agents Chemother 1985;27:137-9.
16. Bonferoni MC, Rossi S, Ferrari F, Bertoni M, Bolhuis GK, Caramella C. On the employment of λ carrageenan in a matrix system. III. Optimization of a λ carrageenan-HPMC hydrophilic matrix. J Control Release 1998;51:231-9.
17. Woolfrey BF, Fox JM, Quall CO. Comparison of minimal inhibitory concentration values determined by three antimicrobic dilution methods for Pseudomonas aeruginosa. Am J Clin Pathol 1981;75:39-44.
18. Piddock LJ. Techniques used for the determination of antimicrobial resistance and sensitivity in bacteria. Antimicrobial Agents Research Group. J Appl Bacteriol 1990;68:307-18.
19. Park J-C, Sung H-J, Lee DH, Park YH, Cho BK, Suh H. Antibacterial effect of antibiotic solution on cellular viability in canine veins. Artif Organs 2001;25:490-4.
20. Park J-C, Sung H-J, Lee DH, Park YH, Cho BK, Suh H. Specific determination of endothelial cell viability in the whole cell fraction from cryopreserved canine femoral veins using flow cytometry. Artif Organs 2000;24:829-33.
21. Park J-C, Sung H-J, Lee DH, Park YH, Cho BK, Suh H. Viability of cells in cryopreserved canine cardiovascular organs for transplantation. Yonsei Med J 2000;41:556-62.
22. Jones KH, Senft JA. An improved method to determine cell viability by simultaneous staining with fluorescein diacetate-propidium iodide. J Histochem Cytochem 1985;33:77-9.
23. Sahagun G, Moore SA, Fabry Z, Schelper RL, Hart MN. Purification of murine endothelial cell cultures by flow cytometry using fluorescein-labeled griffonia simplicifolia agglutinin. Am J Pathol 1989;134:1227-32.
24. Juliano RL, Lopez-Berestein G. Advances in drug delivery, new lives for old drugs: liposomal drug delivery systems reduce the toxicity but not the potency of certain chemotherapeutic agents. Pharm Int 1985;5:164-7.
25. Gupta PK. Drug targeting in cancer chemotherapy: a clinical perspective. J Pharm Sci 1990;79:949-62.
26. Allen TM. A study of phospholipid interactions between high-density lipoproteins and small unilamellar vesicles. Biochim Biophys Acta 1981;640:385-97.
27. Allen TM, Everest JM. Effect of liposome size and drug release properties on the pharmacokinetics of encapsulated drug in rats. J Pharmacol Exp Ther 1983;226:539-44.
28. Gabizon A, Papahadjopoulos D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc Natl Acad Sci U S A 1988;85:6949-53.
29. Yerushalmi S, Margalit R. Bioadhesive, collagen-modified liposomes: molecular and cellular level studies on the kinetics of drug release and on binding to cell monolayers. Biochim Biophys Acta 1994;1189:13-20.
30. Shek PN, Barber RF. Liposomes: a new generation of drugs and vaccine carriers. Mod Med Canada 1986;41:314-26.
31. Lee TC, Zhao YD, Courtman DW, Stewart DJ. Abnormal aortic valve development in mice lacking endothelial nitric oxide synthase. Circulation 2000;101:2345-8.
32. Baker CS, Rimoldi O, Camici PG, Barnes E, Chacon MR, Huehns TY, Haskard DO, Polak JM, Hall RJ. Repetitive myocardial stunning in pigs is associated with the increased expression of inducible and constitutive nitric oxide synthase. Cardiovasc Res 1999;43:685-97.